Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 58

1.

Validation of an algorithm for identifying MS cases in administrative health claims datasets.

Culpepper WJ, Marrie RA, Langer-Gould A, Wallin MT, Campbell JD, Nelson LM, Kaye WE, Wagner L, Tremlett H, Chen LH, Leung S, Evans C, Yao S, LaRocca NG; United States Multiple Sclerosis Prevalence Workgroup (MSPWG).

Neurology. 2019 Mar 5;92(10):e1016-e1028. doi: 10.1212/WNL.0000000000007043. Epub 2019 Feb 15.

PMID:
30770432
2.

The prevalence of MS in the United States: A population-based estimate using health claims data.

Wallin MT, Culpepper WJ, Campbell JD, Nelson LM, Langer-Gould A, Marrie RA, Cutter GR, Kaye WE, Wagner L, Tremlett H, Buka SL, Dilokthornsakul P, Topol B, Chen LH, LaRocca NG; US Multiple Sclerosis Prevalence Workgroup.

Neurology. 2019 Mar 5;92(10):e1029-e1040. doi: 10.1212/WNL.0000000000007035. Epub 2019 Feb 15.

PMID:
30770430
3.

Evaluating the completeness of the national ALS registry, United States.

Kaye WE, Wagner L, Wu R, Mehta P.

Amyotroph Lateral Scler Frontotemporal Degener. 2018 Feb;19(1-2):112-117. doi: 10.1080/21678421.2017.1384021. Epub 2017 Oct 11.

4.

The National Disease Research Interchange and Collaborators on: What Are the Major Hurdles to the Recovery of Human Tissue to Advance Research?

VonDran M, Thomas JA, Freund MP, Ritsick M, Orr M, Kaye WE, Bakker A, Knight P.

Biopreserv Biobank. 2016 Nov 15. doi: 10.1089/bio.2016.29014.mvd. [Epub ahead of print] No abstract available.

5.

Survival and Cause of Death among a Cohort of Confirmed Amyotrophic Lateral Sclerosis Cases.

Paulukonis ST, Roberts EM, Valle JP, Collins NN, English PB, Kaye WE.

PLoS One. 2015 Jul 14;10(7):e0131965. doi: 10.1371/journal.pone.0131965. eCollection 2015.

6.

Geographic Variation of Amyotrophic Lateral Sclerosis Incidence in New Jersey, 2009-2011.

Henry KA, Fagliano J, Jordan HM, Rechtman L, Kaye WE.

Am J Epidemiol. 2015 Sep 15;182(6):512-9. doi: 10.1093/aje/kwv095. Epub 2015 Jun 3.

7.

Results of Florida's Amyotrophic Lateral Sclerosis Surveillance Project, 2009-2011.

Freer C, Hylton T, Jordan HM, Kaye WE, Singh S, Huang Y.

BMJ Open. 2015 Apr 21;5(4):e007359. doi: 10.1136/bmjopen-2014-007359.

8.

Amyotrophic lateral sclerosis surveillance in Baltimore and Philadelphia.

Jordan H, Rechtman L, Wagner L, Kaye WE.

Muscle Nerve. 2015 Jun;51(6):815-21. doi: 10.1002/mus.24488. Epub 2015 Feb 11.

9.

Feasibility of creating a National ALS Registry using administrative data in the United States.

Kaye WE, Sanchez M, Wu J.

Amyotroph Lateral Scler Frontotemporal Degener. 2014 Sep;15(5-6):433-9. doi: 10.3109/21678421.2014.887119. Epub 2014 Mar 6.

10.
11.

Potential residential exposure to toxics release inventory chemicals during pregnancy and childhood brain cancer.

Choi HS, Shim YK, Kaye WE, Ryan PB.

Environ Health Perspect. 2006 Jul;114(7):1113-8.

12.

Lead exposure and birth outcomes in five communities in Shoshone County, Idaho.

Berkowitz Z, Price-Green P, Bove FJ, Kaye WE.

Int J Hyg Environ Health. 2006 Mar;209(2):123-32. Epub 2005 Dec 22.

PMID:
16376613
13.

Wilms' tumor and exposures to residential and occupational hazardous chemicals.

Tsai J, Kaye WE, Bove FJ.

Int J Hyg Environ Health. 2006 Jan;209(1):57-64. Epub 2005 Oct 12.

PMID:
16373202
14.

Secondary contamination of emergency department personnel from o-chlorobenzylidene malononitrile exposure, 2002.

Horton DK, Burgess P, Rossiter S, Kaye WE.

Ann Emerg Med. 2005 Jun;45(6):655-8.

PMID:
15940103
15.

The usefulness of computed tomography in detecting asbestos-related pleural abnormalities in people who had indeterminate chest radiographs: the Libby, MT, experience.

Muravov OI, Kaye WE, Lewin M, Berkowitz Z, Lybarger JA, Campolucci SS, Parker JE.

Int J Hyg Environ Health. 2005;208(1-2):87-99.

PMID:
15881982
16.

Surveillance of hazardous substance emergency events: identifying areas for public health prevention.

Kaye WE, Orr MF, Wattigney WA.

Int J Hyg Environ Health. 2005;208(1-2):37-44.

PMID:
15881977
18.

Impact of occupational exposure on lead levels in women.

Popovic M, McNeill FE, Chettle DR, Webber CE, Lee CV, Kaye WE.

Environ Health Perspect. 2005 Apr;113(4):478-84.

19.

Releases from improper chemical mixing, Hazardous Substances Emergency Events Surveillance system, 1996-2001.

Ernst KP, Wattigney WA, Kaye WE.

J Occup Environ Med. 2005 Mar;47(3):287-93.

PMID:
15761325
20.

Hazardous-chemical releases in the home.

Ruckart PZ, Orr MF, Kaye WE.

J Environ Health. 2004 Dec;67(5):14-9, 32; quiz 35-6.

PMID:
15628191
21.

Hazardous substances releases causing fatalities and/or people transported to hospitals: rural/agricultural vs. other areas.

Berkowitz Z, Horton DK, Kaye WE.

Prehosp Disaster Med. 2004 Jul-Sep;19(3):213-20.

PMID:
15571197
23.

Hydrofluoric acid releases in 17 states and the acute health effects associated, 1993-2001.

Horton DK, Berkowitz Z, Kaye WE.

J Occup Environ Med. 2004 May;46(5):501-8.

PMID:
15167399
25.

Long-term neurobehavioral health effects of methyl parathion exposure in children in Mississippi and Ohio.

Ruckart PZ, Kakolewski K, Bove FJ, Kaye WE.

Environ Health Perspect. 2004 Jan;112(1):46-51.

26.

Hazardous substances events associated with the manufacturing of chemicals and allied products.

Manassaram DM, Orr MF, Kaye WE.

J Hazard Mater. 2003 Nov 14;104(1-3):123-35.

PMID:
14602404
27.
28.

Secondary contamination of ED personnel from hazardous materials events, 1995-2001.

Horton DK, Berkowitz Z, Kaye WE.

Am J Emerg Med. 2003 May;21(3):199-204.

PMID:
12811712
29.

Counterterrorism planning using the Hazardous Substances Events Surveillance system.

Manassaram DM, Orr MF, Kaye WE.

Disaster Manag Response. 2003 Apr-Jun;1(2):35-40.

PMID:
12704318
30.

Acute public health consequences associated with hazardous substances released during transit, 1993-2000.

Horton DK, Berkowitz Z, Haugh GS, Orr MF, Kaye WE.

J Hazard Mater. 2003 Mar 17;98(1-3):161-75.

PMID:
12628784
31.

The public health consequences from acute chlorine releases, 1993-2000.

Horton DK, Berkowitz Z, Kaye WE.

J Occup Environ Med. 2002 Oct;44(10):906-13.

PMID:
12391769
32.

Releases of hazardous substances in schools: data from the Hazardous Substances Emergency Events Surveillance system, 1993-1998.

Berkowitz Z, Haugh GS, Orr MF, Kaye WE.

J Environ Health. 2002 Sep;65(2):20-7, 37, 39.

PMID:
12226905
33.

Hazardous substances emergency events in the agriculture industry and related services in four mid-western states.

Berkowitz Z, Orr MF, Kaye WE, Haugh GS.

J Occup Environ Med. 2002 Aug;44(8):714-23.

PMID:
12185792
34.

Population exposures to I-131 releases from Hanford Nuclear Reservation and preterm birth, infant mortality, and fetal deaths.

Tatham LM, Bove FJ, Kaye WE, Spengler RF.

Int J Hyg Environ Health. 2002 Mar;205(1-2):41-8.

PMID:
12018015
35.
36.

Tetrachloroethylene in drinking water and birth outcomes at the US Marine Corps Base at Camp Lejeune, North Carolina.

Sonnenfeld N, Hertz-Picciotto I, Kaye WE.

Am J Epidemiol. 2001 Nov 15;154(10):902-8.

PMID:
11700244
37.

Recent chemical exposures and blood volatile organic compound levels in a large population-based sample.

Churchill JE, Ashley DL, Kaye WE.

Arch Environ Health. 2001 Mar-Apr;56(2):157-66.

PMID:
11339680
38.

Public health risks of railroad hazardous substance emergency events.

Orr MF, Kaye WE, Zeitz P, Powers ME, Rosenthal L.

J Occup Environ Med. 2001 Feb;43(2):94-100.

PMID:
11227638
39.

Frequency and type of injuries in responders of hazardous substances emergency events, 1996 to 1998.

Zeitz P, Berkowitz Z, Orr MF, Haugh GS, Kaye WE.

J Occup Environ Med. 2000 Nov;42(11):1115-20.

PMID:
11094791
40.

109Cd K x ray fluorescence measurements of tibial lead content in young adults exposed to lead in early childhood.

McNeill FE, Stokes L, Brito JA, Chettle DR, Kaye WE.

Occup Environ Med. 2000 Jul;57(7):465-71.

41.

Factors affecting in vivo measurement precision and accuracy of 109Cd K x-ray fluorescence measurements.

McNeill FE, Stokes L, Chettle DR, Kaye WE.

Phys Med Biol. 1999 Sep;44(9):2263-73.

PMID:
10495120
42.

Neurotoxicity in young adults 20 years after childhood exposure to lead: the Bunker Hill experience.

Stokes L, Letz R, Gerr F, Kolczak M, McNeill FE, Chettle DR, Kaye WE.

Occup Environ Med. 1998 Aug;55(8):507-16.

43.

Assessment of reproductive disorders and birth defects in communities near hazardous chemical sites. I. Birth defects and developmental disorders.

Savitz DA, Bornschein RL, Amler RW, Bove FI, Edmonds LD, Hanson JW, Kaye WE, Khoury M, Kiely M, Lemasters GK, Sever LE, Shepard TH, Spengler RF, Steinberg KK, Yeargin-Allsopp M.

Reprod Toxicol. 1997 Mar-Jun;11(2-3):223-30.

PMID:
9100297
44.

A case-control study to determine risk factors for elevated blood lead levels in children, Idaho.

Maisonet M, Bove FJ, Kaye WE.

Toxicol Ind Health. 1997 Jan-Feb;13(1):67-72.

PMID:
9098951
45.

Risk factors for hazardous substance releases that result in injuries and evacuations: data from 9 states.

Hall HI, Haugh GS, Price-Green PA, Dhara VR, Kaye WE.

Am J Public Health. 1996 Jun;86(6):855-7.

46.

Cluster: a software system for epidemiologic cluster analysis.

Hall HI, Lee CV, Kaye WE.

Stat Med. 1996 Apr 15-May 15;15(7-9):943-50.

PMID:
8861164
47.

Public health consequences of hazardous substance releases.

Hall HI, Dhara VR, Kaye WE, Price-Green P.

Toxicol Ind Health. 1996 Mar-Apr;12(2):289-93. Review.

PMID:
8794541
48.

Health effects related to releases of hazardous substances on the Superfund priority list.

Hall HI, Price-Green PA, Dhara VR, Kaye WE.

Chemosphere. 1995 Jul;31(1):2455-61.

PMID:
7670859
49.

Recall bias in disease status associated with perceived exposure to hazardous substances.

Kaye WE, Hall HI, Lybarger JA.

Ann Epidemiol. 1994 Sep;4(5):393-7.

PMID:
7981847
50.

Surveillance for emergency events involving hazardous substances--United States, 1990-1992.

Hall HI, Dhara VR, Price-Green PA, Kaye WE.

MMWR CDC Surveill Summ. 1994 Jul 22;43(2):1-6.

Supplemental Content

Support Center